Recent study also indicates that linc-ROR contributes to TGFβ-induced acquisition of CD133+ liver CSC and chemoresistance in hepatocellular cancer [43], although the underlying mechanisms have not yet been fully elucidated. Here, LINC-ROR is linked to hepatocellular carcinoma.